Skip to main content
OpenTrials

Clinical trial condition

Lymphadenopathy

Explore clinical trials studying Lymphadenopathy. Study availability and eligibility vary by location and protocol.

192 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Lymphadenopathy trial results

Completed

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

NCT00078949

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations
  • Rush-Presbyterian-St. Luke's Medical Centre Chicago, Illinois, United States
  • Indiana University Medical Center Indianapolis, Indiana, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • University of Cincinnati, Barrett Cancer Centre Cincinnati, Ohio, United States
View all 27 locations
View Trial Details
Completed

Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00416351

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States
  • Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

NCT00052936

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +27 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • II. Medizinische Klinik Aschaffenburg, Germany
View all 174 locations
View Trial Details

Related conditions